Clinical Trial Update: High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated high-dose esomeprazole sodium for preventing rebleeding after successful endoscopic therapy of a bleeding peptic ulcer; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Bleeding Peptic Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2016-03-08